These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19156339)

  • 21. Testosterone deficiency syndrome: benefits, risks, and realities associated with testosterone replacement therapy.
    Hassan J; Barkin J
    Can J Urol; 2016 Feb; 23(Suppl 1):20-30. PubMed ID: 26924592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Declining testicular function in aging men.
    Tenover JS
    Int J Impot Res; 2003 Aug; 15 Suppl 4():S3-8. PubMed ID: 12934044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testosterone replacement in elderly men.
    Baum NH; Crespi CA
    Geriatrics; 2007 Sep; 62(9):15-8. PubMed ID: 17824721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.
    Debruyne FM; Behre HM; Roehrborn CG; Maggi M; Wu FC; Schröder FH; Jones TH; Porst H; Hackett G; Wheaton OA; Martin-Morales A; Meuleman E; Cunningham GR; Divan HA; Rosen RC;
    BJU Int; 2017 Feb; 119(2):216-224. PubMed ID: 27409523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EFFICACY AND SAFETY OF A NEW TOPICAL TESTOSTERONE REPLACEMENT GEL THERAPY FOR THE TREATMENT OF MALE HYPOGONADISM.
    Cunningham G; Belkoff L; Brock G; Efros M; Gittelman M; Carrara D; Neijber A; Ando M; Mitchel J
    Endocr Pract; 2017 May; 23(5):557-565. PubMed ID: 28225313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Comparison of Secondary Polycythemia in Hypogonadal Men Treated with Clomiphene Citrate versus Testosterone Replacement: A Multi-Institutional Study.
    Wheeler KM; Smith RP; Kumar RA; Setia S; Costabile RA; Kavoussi PK
    J Urol; 2017 Apr; 197(4):1127-1131. PubMed ID: 27984109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testosterone replacement therapy and polycythemia in HIV-infected patients.
    Vorkas CK; Vaamonde CM; Glesby MJ
    AIDS; 2012 Jan; 26(2):243-5. PubMed ID: 22008652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Testosterone therapy and cancer risk.
    Eisenberg ML; Li S; Betts P; Herder D; Lamb DJ; Lipshultz LI
    BJU Int; 2015 Feb; 115(2):317-21. PubMed ID: 24684569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypogonadism management and cardiovascular health.
    Auerbach JM; Khera M
    Postgrad Med; 2020 Dec; 132(sup4):35-41. PubMed ID: 32799602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of testosterone gel in the treatment of male hypogonadism.
    Lakshman KM; Basaria S
    Clin Interv Aging; 2009; 4():397-412. PubMed ID: 19966909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Testosterone treatment].
    Rosellen J; Diemer T; Hauptmann A; Wagenlehner F
    Urologie; 2022 Nov; 61(11):1260-1275. PubMed ID: 36279006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular and Cerebrovascular Safety of Testosterone Replacement Therapy Among Aging Men with Low Testosterone Levels: A Cohort Study.
    Loo SY; Azoulay L; Nie R; Dell'Aniello S; Yu OHY; Renoux C
    Am J Med; 2019 Sep; 132(9):1069-1077.e4. PubMed ID: 30953635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Testosterone substitution in patients with hypogonadism].
    Martínez Portillo FJ; Cueva Martínez A; Martin Braun P; Fernández Arancibia MI; Jünemann KP; Alken P
    Arch Esp Urol; 2002 Sep; 55(7):827-38. PubMed ID: 12380312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
    Bhasin S; Brito JP; Cunningham GR; Hayes FJ; Hodis HN; Matsumoto AM; Snyder PJ; Swerdloff RS; Wu FC; Yialamas MA
    J Clin Endocrinol Metab; 2018 May; 103(5):1715-1744. PubMed ID: 29562364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testosterone supplementation: what and how to give.
    Jockenhövel F
    Aging Male; 2003 Sep; 6(3):200-6. PubMed ID: 14628500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Greater saphenous vein thrombosis and testosterone replacement therapy: an occasional association?].
    Bertola G; Bianchi R; Giambona S; Sada S; Berra SA
    Recenti Prog Med; 2017 May; 108(5):239-241. PubMed ID: 28643815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new 2% testosterone gel formulation: a comparison with currently available topical preparations.
    Arver S; Stief C; de la Rosette J; Jones TH; Neijber A; Carrara D
    Andrology; 2018 May; 6(3):396-407. PubMed ID: 29600542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testosterone therapy--what, when and to whom?
    Jockenhövel F
    Aging Male; 2004 Dec; 7(4):319-24. PubMed ID: 15799128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testosterone replacement therapy and cardiovascular events.
    Çatakoğlu AB; Kendirci M
    Turk Kardiyol Dern Ars; 2017 Oct; 45(7):664-672. PubMed ID: 28990951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of male hypogonadism].
    Zitzmann M
    Internist (Berl); 2008 May; 49(5):559-60, 562-4, 566-9. PubMed ID: 18351310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.